Last Update Time:
28-Feb-2025 16:00:00
ISIN:
INE133A01011
Sector:
Consumer Durables
Symbol:
AKZOINDIA
Akzo Nobel India Limited
₹3,165.10
₹-69.65
(-2.15%)
▼
Prev. Close
₹3,234.75
Open
₹3,226.65
Close
₹3,110.25
Range
₹3,006.85 - ₹3,323.36
High
₹3,237.25
Low
₹3,072.90
Ind. Close
₹0.00
VWAP
₹3,113.74
The current stock price of Akzo Nobel India Limited is ₹3,165.10, with a target price range between ₹3,006.85 and ₹3,323.36. The stock has experienced a price change of ₹-69.65 (-2.15%), reflecting recent market volatility.
Today's opening price was ₹3,226.65, while the previous close stood at ₹3,234.75.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Akzo Nobel India Limited Price Chart
Akzo Nobel India Limited Pre Open Market Overview: 28-Feb-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 3226.65
- Previous Close Price: 3234.75
- Change: -8.10%
- Total Traded Volume: 16
- Total Buy Quantity: 111
- Total Sell Quantity: 360
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 3,187.45 | 3.00 | 0.00 |
| 3,204.00 | 6.00 | 0.00 |
| 3,207.00 | 1.00 | 0.00 |
| 3,210.00 | 1.00 | 0.00 |
| 3,226.65 | 4.00 | 0.00 |
| 3,234.75 | 0.00 | 5.00 |
| 3,280.00 | 0.00 | 5.00 |
| 3,282.95 | 0.00 | 8.00 |
| 3,283.10 | 0.00 | 5.00 |
| 3,283.25 | 0.00 | 4.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 111
Total Sell Quantity: 360
Shareholding Patterns of Akzo Nobel India Limited
Key Trade Statistics of Akzo Nobel India Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.21 |
| Traded Value (₹ Cr.) | 6.62 |
| Total Market Cap (₹ Cr.) | 14,413.96 |
| Free Float Market Cap (₹ Cr.) | 2,860.48 |
| Impact cost | 0.13 |
| Quantity Traded | 21,263.00 |
| Deliverable Quantity | 13,718.00 |
| % of Quantity to Traded | 64.52 |
| Security VaR | 13.57 |
| Index VaR | N/A |
| VaR Margin | 13.57 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 17.07 |
| Face Value | 10 |
Key Price Statistics of Akzo Nobel India Limited
The 52-week high for Akzo Nobel India Limited was ₹4,674.00, recorded on 01-Nov-2024. On the other hand, the 52-week low stands at ₹2,267.00, with the lowest value recorded on 13-Mar-2024.
The upper band for trading is ₹3,881.70, and the lower band is ₹2,587.80. The price band is 20%.
The stock's daily volatility stands at 2.12, while the annualized volatility is 40.50. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (01-Nov-2024) | 4,674.00 |
| 52 Week Low (13-Mar-2024) | 2,267.00 |
| Upper Band | 3,881.70 |
| Lower Band | 2,587.80 |
| Price Band (%) | 20 |
| Daily Volatility | 2.12 |
| Annualised Volatility | 40.50 |
| Tick Size | 0.05 |
Key Securities Statistics of Akzo Nobel India Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 28-Jun-2001 |
| Adjusted P/E | 32.96 |
| Symbol P/E | 32.96 |
| Index | NA |
| Macro-Economic Sector | Consumer Discretionary |
| Sector | Consumer Durables |
| Industry | Consumer Durables |
| Basic Industry | Paints |
Security Status of Akzo Nobel India Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Akzo Nobel India Limited
| Subject | Date |
|---|---|
| Disclosure of material issue | 24-Feb-2025 |
| Disclosure of material issue | 24-Feb-2025 |
| Outcome of Board Meeting | 24-Feb-2025 |
| Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company | 22-Feb-2025 |
| Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company | 22-Feb-2025 |
| Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company | 21-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 10-Feb-2025 |
| Copy of Newspaper Publication | 10-Feb-2025 |
Corporate Actions of Akzo Nobel India Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Interim Dividend - Rs 70 Per Share | 19-Nov-2024 |
| 10 | Annual General Meeting/Dividend - Rs 25 Per Share | 25-Jul-2024 |
| 10 | Interim Dividend - Rs 50 Per Share | 16-Feb-2024 |
| 10 | Annual General Meeting/Dividend - Rs 40 Per Share | 27-Jul-2023 |
| 10 | Interim Dividend - Rs 25 Per Share | 21-Feb-2023 |
| 10 | Annual General Meeting/Dividend - Rs 35 Per Share | 28-Jul-2022 |
| 10 | Interim Dividend - Rs 40 Per Share | 22-Feb-2022 |
| 10 | Annual General Meeting/Dividend - Rs 30 Per Share | 05-Aug-2021 |
| 10 | Interim Dividend - Rs 20 Per Share | 17-Feb-2021 |
| 10 | Annual General Meeting/Dividend - Rs 14 Per Share | 20-Aug-2020 |
| 10 | Dividend - Rs 24 Per Share | 31-Jul-2019 |
| 10 | Annual General Meeting/Dividend- Rs 22 Per Share | 25-Jul-2018 |
| 10 | Buyback | 06-Jun-2018 |
| 10 | Annual General Meeting/Dividend - Rs 22/- Per Share | 04-Aug-2017 |
| 10 | Annual General Meeting/Final Dividend Rs.20/- Per Share And Special Dividend Rs.50/- Per Share | 19-Jul-2016 |
| 10 | Annual General Meeting/Dividend - Rs 20/- Per Share | 06-Aug-2015 |
| 10 | Annual General Meeting/Final Dividend Rs.15 Per Share + Special Dividend Rs.60 Per Share | 30-Jul-2014 |
| 10 | Annual General Meeting/Final Dividend Rs.20 Per Share And Special Dividend Rs.60 Per Share | 30-Jul-2013 |
| 10 | Annul General Meeting/Dividend Rs 20 Per Share | 30-Jul-2012 |
| 10 | Buy Back-Tender Offer | 07-Jun-2012 |
Board Meetings of Akzo Nobel India Limited
Financial Results of Akzo Nobel India Limited
Company Directory of Akzo Nobel India Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.AkzoNobel.co.in | Head Office/ Corporate Office | 9th Floor, Magnum Towers Golf Course Extension Road Sector 58 | GURGAON |
| www.AkzoNobel.co.in | Registered Office | 801A, South City Business Park 770, Anandapur Eastern Metropolitan Bypass Near Fortis Hospital | KOLKATA |
| www.AkzoNobel.co.in | Transfer Agent | C B Management Services Pvt. Ltd Rasoi Court, 5th floor 20, Sir R N Mukherjee Road, | KOLKATA |
Insider Trading of Akzo Nobel India Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Akzo Nobel Coatings International B.V. | 4391724600 | Buy |
| 7(2) | Akzo Nobel Chemicals International B.V. | 4391724600 | Sell |
Annual Reports of Akzo Nobel India Limited
Investor Complaints of Akzo Nobel India Limited
Event Calendar of Akzo Nobel India Limited
| Purpose | Details |
|---|---|
| Results/Dividend | To consider, inter alia, Audited Financial Results of the Company for the year ended March 31, 2011 and recommendation of Dividend for the said financial year. |
| Results/Others | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on October 21, 2011 to consider, inter alia, Unaudited Financial Results of the Company for the quarter ended September 30, 2011. The Company has now informed the Exchange that the Board would also consider, inter alia, a proposal for merger/ amalgamation of one or more of Akzo Nobel group companies in India (Akzo Nobel Coatings India Private Limited, Akzo Nobel Car Refinishes India Private Limited and Akzo Nobel Chemicals (India) Limited) with the Company (purpose revised). |
| Results / Buyback | To inter alia (1) Consider the Quarterly Result for the Quarter ending on December 31, 2011. (2) Evaluate the possibility of a share buyback proposal from minority shareholders for implementation at the earliest opportunity; and (3) Examine a proposal for review of the royalty arrangement with Akzo Nobel NV. |
| Board Meeting Deferred | The Company had informed the Exchange regarding a Board meeting to be held on May 21, 2012 to consider, inter-alia, Un-audited Financial Results of the Company for the quarter ended March 31, 2012. The Company has now informed the Exchange that it has been decided to defer the Board Meeting to May 21, 2012 so that the Board could consider the Audited Results of the merged entity for the year 2011-12 and share the same with the shareholders of the Company: (1) The Audited Financial Results of the Company for the year ended March 31, 2012 and (2) Recommendation of Dividend for the said financial year. |
| Results/Dividend/Buyback | The Company had informed the Exchange regarding a Board Meeting of the Company to be held on May 21, 2012 to consider the Audited Results of the merged entity for the year 2011-12 and share the same with the shareholders of the Company: (1) The Audited Financial Results of the Company for the year ended March 31, 2012 and (2) Recommendation of Dividend for the said financial year. The Company has now informed the Exchange that the said meeting will also inter alia be considering a proposal to buy-back its own shares by the Company. (Purpose Revised) |
| Results | To consider, inter-alia, unaudited financial results of the company for the quarter ended December 31, 2012. |
| Results/Dividend | To consider, inter alia, the Audited Financial Results of the Company for the year ended March 31, 2013 and recommendation of Dividend for the said financial year. |
| Results | To consider, inter alia, un-audited financial results of the Company for the quarter ended June 30, 2013. |
| Results | To consider, inter alia, un-audited financial results of the Company for the quarter ended September 30, 2013. |
| Results | To consider, inter alia, un-audited financial results of the Company for the quarter ended December 31, 2013. |
| Results/Dividend | To consider, inter alia, the Audited Financial Results of the Company for the year ended March 31, 2014 and recommendation of Dividend for the said financial year. |
| Results | to consider, inter alia, un-audited financial results of the Company for the quarter ended June 30, 2014. |
| Results | To consider inter-alia, un-audited financial results of the Company for the quarter ended 30th September, 2014. |
| Results | to consider interalia, un-audited financial results of the Company for the quarter ended December 31st, 2014. |
| Results/Dividend | To consider, inter alia, the Audited Financial Results of the Company for the year ended March 31, 2015 and recommendation of Dividend for the said financial year. |
| Results | To consider, inter alia, un-audited financial results of the Company for the quarter ended June 30, 2015. |
| Results | to consider, inter alia, un-audited financial results of the Company for the quarter ended June 30, 2015. |
| Results | To consider, inter alia un-audited financial results of the Company for the quarter ended September 30, 2015. |
| Results | To consider, inter alia, un-audited financial results of the Company for the quarter ended December 31, 2015. |
| Results/Dividend | To consider, inter alia, the Audited Financial Results of the Company for the year ended March 31, 2016, and recommendation of Dividend for the said financial year. |
| Results | To consider, inter alia unaudited financial results of the Company for the quarter ended June 30, 2016. |
| Results | To consider, inter alia, un-audited financial results of the Company for the quarter ended September 30, 2016. |
| Results | To consider, inter alia, un-audited financial results of the Company for the quarter ended December 31, 2016. |
| Results/Dividend | To consider, inter alia, the Audited Financial Results of the Company for the year ended March 31 2017, and recommend Dividend for the said financial year, if any. |
| Results | to consider, inter alia, un-audited financial results of the Company for the quarter ended June 30, 2017. |
| Results | to consider, inter alia, un-audited financial results of the Company for the quarter ended September 30, 2017. |
| Results | to consider, inter alia, un-audited financial results of the Company for the quarter ended December 31, 2017. |
| Buyback | To consider buyback for equity shares |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend |
| Financial Results | To consider and approve the in-audited financial results for the quarter ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results/Dividend | To consider Audited Financial Results of the Company for the year ended 31st March 2019, and recommend Dividend for the said financial year, if any |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2020 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2020 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2020 and dividend |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2021 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Other business matters | To consider other business matters |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2021 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2021 and dividend |
| Financial results | Akzo Nobel India Limited has informed the Exchange about Board Meeting to be held on 05-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial results | Akzo Nobel India Limited has informed the Exchange about Board Meeting to be held on 04-Nov-2022 to consider financial statements for the period ended September 2022 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2022 and dividend |
| Financial Results/Dividend | AKZOINDIA : 23-May-2023 : The Company has informed the Exchange that a Board meeting to be held on May 25, 2023 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 23, 2023, To consider and approve the financial results for the period ended March 31, 2023 and dividend |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2023 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2023 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2023 and dividend |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2024 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2024 and dividend |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2024 |
Share Transfers of Akzo Nobel India Limited
Voting Results of Akzo Nobel India Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 02-JAN-2025 | Postal Ballot | Appointment of Mr. Anil Chaudhry (DIN: 03213517) as an Independent Director of the Company for a period of 3 (Three) years effective 22nd November 2024 till 21st November 2027 (both days inclusive). |
| 02-JAN-2025 | Postal Ballot | Appointment of Mr. Anil Chaudhry (DIN: 03213517) as an Independent Director of the Company for a period of 3 (Three) years effective 22nd November 2024 till 21st November 2027 (both days inclusive). |
| 12-SEP-2024 | Postal Ballot | Appointment of Ms. Namrata Kaul (DIN : 00994532) as an Independent Director of the Company for a period of 3 (Three) years effective 5th August 2024 till 4th August 2027 (both days inclusive) |
| 01-AUG-2024 | AGM | To receive, consider and adopt the Audited Financial Statements (Standalone and Consolidated) for the Financial Year ended 31st March 2024 and the Reports of the Directors and Auditors thereon |
| 01-AUG-2024 | AGM | Ratification of remuneration payable to M/s Chandra Wadhwa & Co., Cost Auditors for the Financial Year 2024-25. |
| 01-AUG-2024 | AGM | To appoint a Director in place of Mr. Rohit Ghanshyamdas Totla (DIN 10391749) who retires by rotation and being eligible, offers himself for re-appointment.n |
| 01-AUG-2024 | AGM | To confirm Interim Dividend as declared and paid and to declare Final Dividend on equity shares of the Company for the Financial Year ended 31st March 2024. |
| 11-JAN-2024 | Postal Ballot | Appointment of Mr. Rohit Ghanshyamdas Totla (DIN: 10391749) as a Director with effect from 16th November 2023. |
| 11-JAN-2024 | Postal Ballot | Appointment of Mr. Rohit Ghanshyamdas Totla (DIN: 10391749) as a Wholetime Director and fixing his Remuneration as the Wholetime Director of the Company for a period of five years commencing from 16th November 2023. |
| 27-SEP-2023 | Postal Ballot | Reappointment of Mr.Rajiv Rajgopal as Managing Director of the Company. |
| 03-AUG-2023 | AGM | Adoption of audited financial statements (standalone and consolidated) for the year ended 31 March 2023 and the Reports of the Directors and Auditors thereon. |
| 03-AUG-2023 | AGM | Ratification of remuneration to Cost Auditors for the year 2023-24. |
| 03-AUG-2023 | AGM | Reappointment of Mr Hemant Sahai as an Independent Director for a period of 3 (three) years from 3 August 2023 to 2 August 2026. |
| 03-AUG-2023 | AGM | Re-appointment of Mr Krishna Rallapalli (DIN 03384607) as a Director who retires by rotation and offers himself for re-appointment. |
| 03-AUG-2023 | AGM | Confirm interim Dividend as declared and paid during financial year 2022-23 and declaration of final Dividend on equity shares for the year ended 31 March 2023. |
| 05-AUG-2022 | AGM | To receive, consider and adopt the audited financial statements (standalone and consolidated) for the year ended 31 March 2022 and the reports of the Directors and Auditors thereon. |
| 05-AUG-2022 | AGM | To consider ratification of remuneration to M/s Chandra Wadhwa & Co., Cost Auditors |
| 05-AUG-2022 | AGM | To consider re-appointment of Mrs Smriti Rekha Vijay (DIN: 03305041) as an Independent Directorn |
| 05-AUG-2022 | AGM | To appoint a Director in place of Mr Oscar Christian Maria Jￃﾳzef Wezenbeek (DIN: 08432564) who retires by rotation and being eligible, offers himself for re-appointment. |
| 05-AUG-2022 | AGM | To confirm interim Dividend as declared and paid and to declare final Dividend on equity shares for the year ended 31 March 2022. |
FAQs on Akzo Nobel India Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.